News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
deVries Tina Marie
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2022 |
4
| deVries Tina Marie (EVP, Research & Development) has filed a Form 4 on RVL Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 9,607 shares
@ $1.13, valued at
$10.9k
|
|
| 11/08/2021 |
4
| deVries Tina Marie (EVP, Research & Development) has filed a Form 4 on Osmotica Pharmaceuticals plc|
Txns:
| Granted 216,944 options to buy
@ $1.8, valued at
$390.5k
|
|
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2020 |
4
| deVries Tina Marie (EVP, Research & Development) has filed a Form 4 on Osmotica Pharmaceuticals plc|
Txns:
| Granted 71,550 shares
@ $0
Granted 71,550 options to buy
@ $0 |
|
| 01/30/2020 |
4
| deVries Tina Marie (EVP, Research & Development) has filed a Form 4 on Osmotica Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 9,140 shares
@ $7, valued at
$64k
|
|
| 01/28/2019 |
4
| deVries Tina Marie (EVP, Research & Development) has filed a Form 4 on Osmotica Pharmaceuticals plc|
Txns:
| Granted 104,849 shares
@ $0 |
|
| 10/18/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|